Year: 2024

340B Health System’s Suit Against Drugmakers Seeks to Recover ‘Hundreds of Millions in Overpayments’

January 23, 2024 Rich Daly, Editor in Chief Views

Calif-based Adventist Health System/West and four drugmakers are clashing in federal district court over allegations of 340B overcharges.

A California health system is continuing a previously sealed whistleblower case it first filed in 2021 against several pharmaceutical companies. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

New Medicaid Policy Change Could Reduce 340B Savings, Cause Drug Discontinuations, Warn Stakeholders

January 23, 2024 William Newton, Associate Editor/Senior Writer Views

A Medicaid drug rebate policy change that recently took effect could lead to reduced 340B savings and drug discontinuations.

A Medicaid policy change that took effect at the start of 2024 could indirectly lead to lower 340B savings and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Iowa 340B Contract Pharmacy Bill Introduced; Companion Bills Debut in West Virginia, Oklahoma

January 23, 2024 William Newton, Associate Editor/Senior Writer Views

Iowa is the latest state to introduce a bill to shield 340B contract pharmacy arrangements from manufacturer restrictions.

A key healthcare committee in the Iowa House of Representatives recently introduced a bill that would bar drug manufacturer restrictions [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

$7.8 Billion in Refunds from Underpayments to 340B Hospitals Begin to Roll In

January 19, 2024 Rich Daly, Editor in Chief Views

A map of Medicare administrative contractors' (MAC's) jurisdictions. MACs in more than half the states have begun to issue refunds to 340B hospitals for unlawful Medicare cuts from 2018-2022.

Medicare administrative contractors (MACs) covering more than half the states have initiated lump sum repayments to 340B hospitals, after getting [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Latest Cassidy Probe Adds to Growing Scrutiny of 340B Contract Pharmacies, TPAs

January 19, 2024 William Newton, Associate Editor/Senior Writer Views

The drug industry and 340B program advocates offered mixed reactions Monday to a key senator’s latest inquiries into drugmakers’ contract pharmacy restrictions as part of an ongoing congressional probe of the drug pricing program.

An influential senator’s inquiry into the nation’s two largest 340B pharmacy chains comes amid growing scrutiny into 340B contract pharmacies [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AbbVie Pushes to Block Louisiana 340B Contract Law, New State AG Takes Office

January 19, 2024 William Newton, Associate Editor/Senior Writer Views

In a recent federal court filing, Louisiana Attorney General Liz Murrill's office said it had not moved to enforce a state 340B contract pharmacy law.

Pharmaceutical giant AbbVie recently urged a federal judge to rule on its suit against Louisiana’s 340B contract pharmacy law without [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Senator Cassidy Expands 340B Inquiry to Two Major Contract Pharmacies

January 18, 2024 William Newton, Associate Editor/Senior Writer Views

Sen. Bill Cassidy (R-La.) expanded his ongoing inquiry into 340B revenue with letters to two major contract pharmacies.

The top Republican on an influential Senate committee yesterday asked the nation’s two largest contract pharmacy companies for detailed information [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Two More States Introduce 340B Contract Pharmacy Protection Bills

January 17, 2024 William Newton, Associate Editor/Senior Writer Views

Two high-ranking West Virginia state senators recently introduced a bipartisan bill that would prohibit drug manufacturer restrictions on 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Drug Makers Issue Record Number of 340B Refunds in 2023, Merck First to Refund in 2024

January 17, 2024 Rich Daly, Editor in Chief Views

Drugmakers issued a record 41 refunds to 340B covered entities in 2023.

Drugmakers issued a record 41 refunds to 340B covered entities in 2023. And Merck is the first to announce it [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live